Vistin Pharma ASA: Mandatory notification of trade

22 Mar 2024
www.globenewswire.com
Vistin Pharma ASA: Mandatory notification of trade
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and board member of Vistin Pharma ASA. Pactum Vekst AS is fully owned by Pactum AS. The shares in Vistin Pharma are sold to one of Pactum’s shareholders, as part of a share buy-back process in Pactum.
After the transaction, Pactum Vekst AS owns 2 991 773 shares in Vistin Pharma ASA.
Please see attached document in accordance with the Market Abuse Regulation article 19.
This notification has been submitted pursuant to the Securities Trading Act section 5-12.
Attachment
Vistin Pharma_Notification of trade_Espen Marcussen_board member


For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.